Compare Abeona Therapeutics Inc (ABEO) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Kimberly Clark Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Kimberly Clark Corp trades at $108.02 (market cap $36.11B). The key difference: Kimberly Clark Corp is far larger — about 85.7× Abeona Therapeutics Inc's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | KMB | |
|---|---|---|
Market Cap | $421.19M | $36.11B |
Sector | Health | Consumer Staples |
52-Week High | $7.45 | $134.81 |
52-Week Low | $4.17 | $93.05 |
Enterprise Value | $276.10M | $41.67B |
Dividend Yield | — | 4.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
